Form 8-K - Current report:
SEC Accession No. 0001663577-25-000033
Filing Date
2025-01-23
Accepted
2025-01-23 15:20:44
Documents
14
Period of Report
2025-01-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K skvi8k_012325.htm   iXBRL 8-K 22950
5 PRESS RELEASE, DATED JANUARY 23, 2025 ex99_1.htm EX-99.1 14180
  Complete submission text file 0001663577-25-000033.txt   208511

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE skvi-20250123.xsd EX-101.SCH 3024
3 XBRL LABEL FILE skvi-20250123_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE skvi-20250123_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT skvi8k_012325_htm.xml XML 3349
Mailing Address 6320 S SANDHILL ROAD UNIT 9 LAS VEGAS NV 89120
Business Address 6320 S SANDHILL ROAD UNIT 9 LAS VEGAS NV 89120 702-433-7154
SKINVISIBLE, INC. (Filer) CIK: 0001085277 (see all company filings)

EIN.: 880344219 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25911 | Film No.: 25549670
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)